M Y Brusniak

Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.

K. Neve, M. Brusniak, R. S. Pearlman, 1996, Journal of medicinal chemistry.

CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.

R E Wilcox, M Y Brusniak, R S Pearlman, 1998, Journal of medicinal chemistry.

CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.

K. Neve, M. Brusniak, M. Teeter, 2000, Journal of medicinal chemistry.